Introduction
Autopsy studies are an important part of medical education as well as of high quality care [1] [2] [3] . They are also a source of knowledge of new diseases, their treatment and treatment-related toxicity [4] [5] [6] [7] [8] [9] [10] . There is, however, a progressive decline in the number of autopsies carried out [11] . In the US, the autopsy rate fell from 50% in the 1940s to 15% by the 1980s [12] [13] [14] [15] [16] .
Hodgkin's disease (HD) is a curable disease, although the improvement in therapeutic outcome has reached a plateau since the earlier 1980s. Since then, researchers have striven to decrease treatment morbidity. The ability to identify long-term complications after treatment of HD is an important factor in the development of successful treatments for the disease. About 70% of all patients can now be cured and in patients with early disease this figure approaches 95%. The substantial incidence of deaths due to causes other than HD was not acknowledged until the past decade. However, the impact of other fatal complications is now more widely recognized, and modifications in staging and treatment have been introduced to decrease these risks.
Our aim is to study a series of autopsies in patients with Hodgkin's disease, analyzing the cause of death and comparing the premortem and postmortem findings. The present series offers additional information about this particular aspect of HDK, that has been also analyzed in previous reports [17] [18] [19] [20] 22] .
Aside from analyzing the causes of death, it was also of interest to learn whether there have been significant changes in the natural history of the disease or in treatment-related toxicity during this period. On the other hand, this study allowed the investigation of a little explored aspect, that is whether the performance of autopsy caused a bias in postmortem assessment when compared to studies based on clinical data alone.
Patients and methods
All the patients diagnosed as having HD, in the university hospital 'Clinica Puerta de Hierro' between 1967 and 1996, were reviewed. To be included, all patients had to have a pathologically confirmed diagnosis of HD. The histological classification was based on the approach of Lukes and Butler [21] . When the subtype could not be determined, patients were categorized as having non-specified HD (HD-NS). The extension study and clinical classification followed the Rye criteria (1971) and those from further revisions in Ann Arbor [22] and the Cotswold consensus [23, 24] . Chemotherapy included combinations of MOPP [25] (mechlorethamine, vincristine, procarbazine and prednisone). ABVD [26] (doxorubicin, bleomycin, vinblastine and dacarbazine) or both. Radiation therapy was given according to Kaplan [27] , adapted in our hospital by Aragon et al. [28] .
A complete response was defined as the absence of any clinical or radiological evidence of disease for at least four weeks after treatment (30) 60 (12) 57 (12) 63 (13) 16 (3) 51 (10) 188 (39) 176 (36) 61 (12) 38 (8) 23 (5) 268 (55) 218 (45) 259 (53) 224 (47) 196 (40) 136 (28) 149 (31) 5 (D 450 (92,5) 140 (28) cessation. In cases of residual mass, a response was considered to be complete when the mass remained stable for at least one month after radiation therapy or throughout two consecutive chemotherapy cycles [29] and there were no clinical or analytical signs of active lymphoma. An incomplete response was any outcome that did not meet the above mentioned criteria, although there was a partial response or stabilization. To ascertain the vital status, all patients were contacted and invited to come to the clinic. All those who could not be contacted were considered to be lost to follow-up. Overall survival was expressed in months after diagnosis.
Autopsy studies
The autopsies performed in our series, 40 of 144 nonsurvivors patients, is the regular rate of autopsies in our hospital, independently of the patient's pathology. They are made after family consent, and no substantial variations during the 29 years of this study have been experimented. No autopsy is made when the patient died outside of the hospital. The autopsy study protocol included, complete evisceration of the three large cavities and. in all cases, extraction of vertebral bodies and spinal cord. Routine tests also included microbiological cultures of intracardiac blood, pericardium, pleura or ascitic effusion when present. Macroscopic examination of each viscera and complete dissection of vessels and excretory ducts were performed. Additionally, more complex techniques were employed when any pathological condition was found. Samples of bilateral neck, supraclavicular, axillary, mediastinic, lung, hilar, periaortic, mesenteric, splenic hilar, portohepatic, bilateral iliac and inguinal lymph nodes were taken. Vertebral bone marrow was analyzed, as was any other bone when pathology was suspected. The incidence of residual HD, histopathological effects of treatment or second neoplasm was then studied. The clinical data and the pathological findings were reviewed and the cause of death determined in each case. The slides were reviewed in all cases with autopsy and two cases were excluded in which diagnosis remained unclear. A total of 40 autopsies, with confirmed diagnosis of HD, were studied.
Statistical analysis
This is descriptive statistical study in which the categorical variables are tabulated according to their absolute value. The continuous variables are expressed in terms of the mean and 95% confidence interval (95% CI), with the exception of the median and range for survival time. The categorical variables were compared by means with Fisher's exact test. We considered /'-values of less than 0.05 to be significant. All comparisons were two-tailed. The estimated of survival probabilities were made using the product-limit method [30] .
Results

Population study
We studied 486 patients, with a median follow-up time 8 years (range 0-26 years). The follow-up was complete for 459 (96%). The median age at diagnosis was 30.1 years (range 4-85 years). Sex ratio (male: female) at diagnosis was 1.7:1 (Table 1) . One hundred forty-four patients died (30%). The overall survival was 80% (95% CI: 76-83) at 5 years, 70% (95% CI: 65-75) at 10 years, and 66% (95% CI: 61-71) 15 years after diagnosis. The median survival time was 21.1 years (95% CI: 19-23 years).
Autopsy was performed in 40 of the 144 nonsurvivors (28%). The comparison of their clinical features with those of the nonsurvivors in whom autopsy was not carried out revealed a significantly greater number of splenectomies and complete responses in the non-autopsy group. The remaining clinical features were similar for both groups (Table 2) . Two medico-legal autopsies were performed outside our center and, although we received the results, they were not included in the present study since they were forensic in nature.
Cause of death
Overall, the most common clinical cause of death was tumor progression (37%), followed by infection (27%) and second tumor (20%). Infection was the major cause and significantly more frequent in those patients with autopsy study (43% vs. 19%). Deaths due to second tumors were more frequent in patients without autopsy study (24% vs. 8%). No other causes of death showed statistically significant differences between the two groups (Table 3) . (5) 3 (8) 11 (27) 14 (35) 12 (30) 27 (67) 17 (43) 23 (57) 15 (37) 25 (63) 17 (43) 11 (27) (26) 23 (22) 4 (4) 10 (10) 10 (10) 32 (31) 44 (42) 18 (17) 56 (54) 62 (60) 42 (40) 59 (56) 45 (44) 39 (38) 34 ( Because of rounding up the total of some percentages is not 100. between the clinical diagnosis and final pathology in 23 cases (57%) and discordance in the remaining 17 (43%). Of these 17, the clinician suspected tumor progression in 15 (Table 4 ). In the remaining two patients, who had histories of fever of unknown origin and asthenia of several months' duration, HD had not been suspected. Both presented diffuse liver disease and the histological study disclosed the presence of lymphocyte depletion. In the 15 cases of clinicopathological discordance, infection was the suspected cause of death in 10. In three cases, the patients died of chemotherapy-related causes (MOPP-induced liver failure, enteritis and malabsorption after combined chemotherapy and radiation therapy, and the third, brain radionecrosis). Tumor progression was the major cause of death in those patients without autopsy (38%) and was detected in 35% of the patients with an autopsy study.
Tumor location at autopsy
The lymph nodes were the most frequent location of HD activity, which was detected there in 20 of 40 patients (50%), followed by spleen in 9 of 25 patients (36%), bone Abbreviations: CT -chemotherapy; RT -radiotherapy. in 10 of 40 (25%) lung in 9 of 40 (23%) and liver in 9 of 40 (23%) ( Table 5) .
A site of active HD was erroneously identified in 28 cases, including 9 false positives in lung and abdominal nodes, 4 in liver, 3 in bone and another 3 cases with meningeal, pleural and pancreatic node involvement.
Location of other lesions at autopsy
In the autopsy studies performed in our patients, a number of lesions unrelated to death and probably related to treatment morbidity were found. The gastrointestinal (GI) tract was primarily involved in 10 patients (25%) who presented with upper GI bleeding; this was the cause of death in only one patient who had massive tumor growth diagnosed as HD at necropsy. Liver fibrosis was encountered in six patients and in peritoneum in four, radiation-induced necrotic enteritis in three and esophagitis of iatrogenic origin in three. Atherosclerosis (aortic, coronary, renal and cerebral) was observed in 20 patients. Involvement of the respiratory system included ' The tumor location at autopsy can be multiple. ' Because of rounding up the total of some percentages is not 100.
eight cases of fibrinous pleuritis, five of pulmonary fibrosis and four of postradiation therapy pneumonitis.
Discussion
Autopsy is the most comprehensive approach to gain knowledge on diseases and their treatment-related effects and to prove causes of death. It is also one of the best quality control methods in medicine [31, 32] . Autopsy studies in the general population have demonstrated previously suspected diagnoses that could have entailed a different therapeutic approach and very likely a prolongation of the survival of these patients [33, 34] . The autopsies in our series proved that infections were the principal cause of death, being implicated in 43% of cases, followed by tumor progression, which is encountered in 35% of all autopsy studies. In the Stanford HD autopsy series, the incidence of death due to infection amounted to 45%, similar to the rate observed in our study, although slightly higher than the report from the British National Lymphoma Investigation series [35] where infection was responsible for 35% of the 774 intercurrent deaths recorded. In the International Database on Hodgkin's disease, infection was the cause of 34% of all intercurrent deaths [36] .
Infections are likely to remain undetected and their symptoms can mimic tumor progression. This fact may account for the significantly higher percentage of deaths due to infection found at autopsy as compared to the clinical assessment. In our study, 10 patients died of clinically unsuspected infection diagnosed at autopsy. Thus, a 25% reduction in mortality could have been attained if the clinical suspicion and adequate treatment had been established.
Despite technological advances, the number of inaccurate clinical diagnoses remains high. The rate of discordance between clinical and autopsy diagnoses of malignant neoplasms is 44%, according to a recent study [37] . In our study, in Hodgkin's disease alone, there was a discrepancy between the cause of death and the final conclusion of the pathologist in 43% of cases. We have found that the locations most frequently inducing errors were abdominal and lung nodes, and less frequently liver and bone.
Currently, is admitted that spite of high quality of the diagnosis techniques [38] [39] [40] , 2% of HD patients at diagnosed autopsy. In our series, two patients were diagnosed as having HD at autopsy. When this occurs, HD is usually associated with lymphocyte depletion, accompanied by pancytopenia, fever, liver involvement and advanced disease, with minimal node involvement [41] . When nodes are affected, the involvement is usually infradiaphragmatic [42 43 ]. Liver involvement is common and may lead to the suspicion of a primary liver disease -in some cases it presents as a liver granuloma [44] -a fact that contrasts with the low incidence of liver involvement in HD patients (6%) [19, 20] . In large series, the most common neoplasm-related cause of fever of unknown origin is lymphoma, occurring in around 30% of cases [45, 46] , especially among patients under 40 years of age [47] . In this study may appear some limitations, but as our hospital has been a reference center for HD for many years, other center may have referred those patients with worse prognoses to ours and the sample studied may not be representative of the population of patients with HD.
When the disease extension is compared to that documented before the existence of active treatments [48] , an overall decrease in visceral involvement is observed: lung (46% vs. 22%), liver (65% vs. 22%), bone marrow (43% vs. 5%) and kidney (13% vs. 3%). These findings may explain that is possible to achieve a good complete remission rate of disease when there is bone marrow or visceral involvement at diagnosis, as recently has been reported [49] . Offering a new prognosis to these situations regarding earlier considerations when no fine chemotherapy was available [50] . On the other hand, these findings provide evidence of the difficulty of removing lymphoma from some locations, which may explain late relapses, and may help in the design of therapeutic approaches.
As regards the nonfatal findings at autopsy, wide fibrous areas are observed in nodes and spleen. The awareness of this situation may help avoid unnecessary treatment based on the misinterpretation -persistent adenopathy [51, 52] -of therapeutic responses. A number of nonfatal lesions have been observed in the gastrointestinal tract and the cardiorespiratory system. These organs are the principal targets for drugs used in polychemotherapy combinations. Although the lesions may contribute very little to patient deaths, the knowledge of their existence may help to decrease their morbidity.
